Literature DB >> 23671819

Heart failure with preserved ejection fraction in African Americans: The ARIC (Atherosclerosis Risk In Communities) study.

Deepak K Gupta, Amil M Shah, Davide Castagno, Madoka Takeuchi, Laura R Loehr, Ervin R Fox, Kenneth R Butler, Thomas H Mosley, Dalane W Kitzman, Scott D Solomon.   

Abstract

OBJECTIVES: In an entirely African-American cohort, we compared clinical characteristics, cardiac structure and function, and all-cause mortality in patients with heart failure (HF) with preserved ejection fraction (HFpEF) in relation to patients with heart failure with reduced ejection fraction (HFrEF) and those without HF.
BACKGROUND: African Americans are at increased risk for HF. Nevertheless, there are limited phenotypic and prognostic data in African Americans with HFpEF compared with those with HFrEF and those without HF.
METHODS: Middle-aged African Americans from the Jackson, Mississippi, cohort of the ARIC (Atherosclerosis Risk In Communities) study (n = 2,445) underwent echocardiography between 1993 and 1995. HF prevalence was available in 1,962 patients for whom left ventricular ejection fraction (LVEF) could be quantified. Participants with HF were categorized as having HFpEF (LVEF ≥50%), HFrEF (LVEF <50%), or no HF, with comparisons made between groups.
RESULTS: HF was identified in 116 (5.9%) participants (HFpEF n = 85 [73%]; HFrEF n = 31 [27%]). Compared with those without HF, those with HFpEF were older, were more likely to be female, and had more frequent comorbidities and concentric hypertrophy. In relation to HFrEF, those with HFpEF were more likely to be female but less likely to have coronary heart disease, diabetes mellitus, chronic kidney disease, left atrial enlargement, and eccentric hypertrophy. Over a median 13.7 years of follow-up, risk of death differed between groups, with age- and sex-adjusted hazard ratios of 1.51 (95% confidence interval: 1.01 to 2.25) for HFpEF versus those without HF and 2.50 (95% confidence interval: 1.37 to 4.58) for HFrEF versus HFpEF.
CONCLUSIONS: In this cohort of middle-aged African Americans, HFpEF was the most common form of HF and was associated with a substantially better prognosis than HFrEF but worse than those without HF.

Entities:  

Mesh:

Year:  2013        PMID: 23671819      PMCID: PMC3650857          DOI: 10.1016/j.jchf.2013.01.003

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN: 2213-1779            Impact factor:   12.035


  56 in total

1.  Comparison of outcomes of white versus black patients hospitalized with heart failure and preserved ejection fraction.

Authors:  Ildiko Agoston; Craig S Cameron; David Yao; Ariel Dela Rosa; Douglas L Mann; Anita Deswal
Journal:  Am J Cardiol       Date:  2004-10-15       Impact factor: 2.778

2.  Trends in prevalence and outcome of heart failure with preserved ejection fraction.

Authors:  Theophilus E Owan; David O Hodge; Regina M Herges; Steven J Jacobsen; Veronique L Roger; Margaret M Redfield
Journal:  N Engl J Med       Date:  2006-07-20       Impact factor: 91.245

Review 3.  Increased prevalence of concentric left ventricular hypertrophy in African-Americans: will an epidemic of heart failure follow?

Authors:  Sandeep Kamath; David Markham; Mark H Drazner
Journal:  Heart Fail Rev       Date:  2006-12       Impact factor: 4.214

4.  Outcomes by race and etiology of patients with left ventricular systolic dysfunction.

Authors:  Kevin L Thomas; Mark A East; Eric J Velazquez; Robert H Tuttle; Linda K Shaw; Christopher M O'Connor; Eric D Peterson
Journal:  Am J Cardiol       Date:  2005-10-01       Impact factor: 2.778

5.  Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients.

Authors:  Scott D Solomon; Nagesh Anavekar; Hicham Skali; John J V McMurray; Karl Swedberg; Salim Yusuf; Christopher B Granger; Eric L Michelson; Duolao Wang; Stuart Pocock; Marc A Pfeffer
Journal:  Circulation       Date:  2005-12-05       Impact factor: 29.690

6.  Outcome of heart failure with preserved ejection fraction in a population-based study.

Authors:  R Sacha Bhatia; Jack V Tu; Douglas S Lee; Peter C Austin; Jiming Fang; Annick Haouzi; Yanyan Gong; Peter P Liu
Journal:  N Engl J Med       Date:  2006-07-20       Impact factor: 91.245

7.  Comparison of African-American patients with systolic heart failure versus preserved ejection fraction.

Authors:  Nurcan Ilksoy; Matt Hoffman; Renee H Moore; Kirk Easley; Terry A Jacobson
Journal:  Am J Cardiol       Date:  2006-08-02       Impact factor: 2.778

8.  Improving the detection and diagnosis of congestive heart failure.

Authors:  L Wilhelmsen; H Eriksson; K Svärdsudd; K Caidahl
Journal:  Eur Heart J       Date:  1989-08       Impact factor: 29.983

Review 9.  Heart failure in African Americans.

Authors:  Clyde W Yancy
Journal:  Am J Cardiol       Date:  2005-08-09       Impact factor: 2.778

10.  Metabolic syndrome and echocardiographic left ventricular mass in blacks: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Cecil M Burchfiel; Thomas N Skelton; Michael E Andrew; Robert J Garrison; Donna K Arnett; Daniel W Jones; Herman A Taylor
Journal:  Circulation       Date:  2005-08-01       Impact factor: 29.690

View more
  30 in total

Review 1.  Circulating biomarkers in patients with heart failure and preserved ejection fraction.

Authors:  Eileen O'Meara; Simon de Denus; Jean-Lucien Rouleau; Akshay Desai
Journal:  Curr Heart Fail Rep       Date:  2013-12

2.  Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: findings from the echocardiographic study of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) Trial.

Authors:  Amil M Shah; Brian Claggett; Nancy K Sweitzer; Sanjiv J Shah; Inder S Anand; Eileen O'Meara; Akshay S Desai; John F Heitner; Guichu Li; James Fang; Jean Rouleau; Michael R Zile; Valetin Markov; Vyacheslav Ryabov; Gilmar Reis; Susan F Assmann; Sonja M McKinlay; Bertram Pitt; Marc A Pfeffer; Scott D Solomon
Journal:  Circ Heart Fail       Date:  2014-08-13       Impact factor: 8.790

3.  Diastolic wall strain is associated with incident heart failure in African Americans: Insights from the atherosclerosis risk in communities study.

Authors:  Daisuke Kamimura; Takeki Suzuki; Michael E Hall; Wanmei Wang; Michael D Winniford; Amil M Shah; Carlos J Rodriguez; Kenneth R Butler; Thomas H Mosley
Journal:  J Cardiol       Date:  2017-12-06       Impact factor: 3.159

Review 4.  Heart Failure With Preserved Ejection Fraction In Perspective.

Authors:  Marc A Pfeffer; Amil M Shah; Barry A Borlaug
Journal:  Circ Res       Date:  2019-05-24       Impact factor: 17.367

5.  Elevated serum osteoprotegerin is associated with increased left ventricular mass index and myocardial stiffness.

Authors:  Daisuke Kamimura; Takeki Suzuki; Anna L Furniss; Michael E Griswold; Iftikhar J Kullo; Merry L Lindsey; Michael D Winniford; Kenneth R Butler; Thomas H Mosley; Michael E Hall
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2017-12       Impact factor: 2.160

6.  The complex relationship of race to outcomes in heart failure with preserved ejection fraction.

Authors:  Jerry H Gurwitz; David J Magid; David H Smith; Grace Hsu; Sue Hee Sung; Larry A Allen; David D McManus; Robert J Goldberg; Alan S Go
Journal:  Am J Med       Date:  2014-12-30       Impact factor: 4.965

Review 7.  Ventricular remodeling in heart failure with preserved ejection fraction.

Authors:  Amil M Shah
Journal:  Curr Heart Fail Rep       Date:  2013-12

8.  Higher plasma leptin levels are associated with reduced left ventricular mass and left ventricular diastolic stiffness in black women: insights from the Genetic Epidemiology Network of Arteriopathy (GENOA) study.

Authors:  Daisuke Kamimura; Takeki Suzuki; Wanmei Wang; Matthew deShazo; John E Hall; Michael D Winniford; Iftikhar J Kullo; Thomas H Mosley; Kenneth R Butler; Michael E Hall
Journal:  Hypertens Res       Date:  2018-06-15       Impact factor: 3.872

9.  The Obesity and Heart Failure Epidemics Among African Americans: Insights From the Jackson Heart Study.

Authors:  Arun Krishnamoorthy; Melissa A Greiner; Alain G Bertoni; Zubin J Eapen; Emily C O'Brien; Lesley H Curtis; Adrian F Hernandez; Robert J Mentz
Journal:  J Card Fail       Date:  2016-03-11       Impact factor: 5.712

10.  Atrial Fibrillation and Race - A Contemporary Review.

Authors:  Michael K D Amponsah; Emelia J Benjamin; Jared W Magnani
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.